Topics:

Rheumatology Network

Tech Tips Series #1: Managing the Information Barrage

Our goal at RheumNet is always to help you manage the constant flood of online information for rheumatologists. Here, in the first installment of a new series, Advisory Board member Suleman Bhana MD shares tips for saving, sorting, and retrieving journal articles.

Recent Content

psoriatic arthritis

Agents that target the TH17-interleukin pathway show promise in psoriatic arthritis, as alternatives for patients who don't benefit from TNFα blockers. This slide show describes their mode of action and potential.

Articles in two different internal medicine journals last week discussed when and how to use opioids for rheumatologic pain, despite their hazards and limitations.

The JAK1 and JAK2 inhibitor baricitinib has shown significant results in a second Phase 3 trial for rheumatoid arthritis.

The first study to ask about variance between physicians and patients in judging the severity of psoriatic arthritis shows that, as with rheumatoid arthritis, they don't reach similar conclusions.

prior authorization

Prior authorizations have begun to spread pandemic-like from high-cost biologics to treatments used routinely in rheumatology. The time burden on rheumatologists is insupportable, contends the author, who says it's time to take action.

Two biosimilars for the TNF inhibitor infliximab are now licensed and distributed in Europe. A German rheumatologist wonders what difference the option to prescribe Inflektra and Remsima will make, if any.

low back pain

Do you think heavy lifting with degenerative osteoarthritis is the major cause of low back pain? A new study designed to identify modifiable triggers finds relative youth, time of day, and perhaps lack of planning to be key factors.

By clicking Accept, you agree to become a member of the UBM Medica Community.